Drupal.behaviors.print = function(context) {window.print();window.close();}>
RXi Changes Name, Plans to Spin out RNAi Operations into New Public Company
September 29, 2011
RXi Changes Name, Plans to Spin out RNAi Operations into New Public Company
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Galena Preps for RXi Spinout as Investor Lawsuits Proceed
March 1, 2012 / Gene Silencing News
SEC Filing Indicates RXi Will Trade as 'Penny Stock,' Face Alnylam IP Challenge
December 15, 2011 / Gene Silencing News
People in the News: Paul Dorman, Curtis Lockshin
April 25, 2013 / Gene Silencing News
Following Private Placement, RXi Has Funds to Last into 2015
April 4, 2013 / Gene Silencing News
RXi Releases Blinded Phase I Data Hinting at Efficacy of Anti-Scarring Drug, On Track for Phase II
February 21, 2013 / Gene Silencing News